Skip to content

IMDX IMDX Total Liabilities

Total Liabilities at other companies

CareDx logo
CareDxCDNA
$278K-99.7%
Guardant Health logo
Guardant HealthGH
$2.1B+31.4%
Natera, Inc. logo
Natera, Inc.NTRA
$125.55M-74.5%
Fulgent Genetics, Inc. logo
Fulgent Genetics, Inc.FLGT
$112.22M+35.2%
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
$2.94B+3.2%
Agilent Technologies logo
Agilent TechnologiesA
$5.94B-1.3%

Other financials

Income statement

See full
Revenue$32.0K-98.5%
Gross profit$15.0K-98.9%
Operating income-$4.4M+35.1%
Net income-$4.3M+35.7%
EPS (diluted)-$0.12+53.8%

Balance sheet

See full
Cash & equivalents$28.2M-9.1%
Total debt$2.9M-13.5%
Total equity-$10.7M-205%
Total assets$40.4M-33.0%

Cash flow

See full
Operating cash flow-$7.6M-30.8%
CapEx$613.0K+99.7%
Free cash flow-$8.3M-34.3%

Valuation

See full
Market cap$185.35M+92.3%
Enterprise value$160.03M+113%
P/S95.1×+72.5×

Profitability

See full
Gross margin51.3%-3.0pp
Operating margin-2,500.7%+4,459pp
Net margin-2,454.6%+4,017pp
FCF margin-1,409.7%-6,023pp

Returns & leverage

See full
Return on equity-532.9%-717pp
Debt / equity2.9×+2.8×
Current ratio2.5×-1.2×

Where this comes from

Reported directly by IMDX in its filing.

Tagged under the XBRL concept us-gaap:Liabilities.

The official record: IMDX’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about IMDX's total liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is IMDX's total liabilities?
IMDX (IMDX) reported total liabilities of $51.12M in Q1 2026.
How has IMDX's total liabilities changed year-over-year?
IMDX's total liabilities increased by 1.9% year-over-year, from $50.14M to $51.12M.
What is the long-term trend for IMDX's total liabilities?
Over 5 years (2020 to 2025), IMDX's total liabilities has grown at a 21.1% compound annual growth rate (CAGR), from $21.94M to $57.22M.
What does total liabilities mean?
The sum of all current and non-current obligations — everything the company owes to creditors, employees, governments, and other stakeholders.